ATLANTA, Georgia — A combination of gene-expression testing (BronchoGen, Allegro Diagnostics) and diagnostic bronchoscopy significantly improves accuracy in the diagnosis of lung cancer, compared with ...

Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon ...

Guardant Health is joining in on the American Lung Association’s (ALA’s) push to raise awareness about lung cancer screening and biomarker testing. The U.S. Preventive Services Task Force recommends ...

Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...

Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...

Radon is one of the leading causes of lung cancer in the U.S., but it is something that is entirely avoidable if you know to ...

Biodesix, Inc. has announced that new research will be showcased at upcoming conferences, including the ISPOR 2025 Annual Meeting in Montreal and the ATS 2025 International Conference in San Francisco ...

Credit: Getty Images The road to race-neutral pulmonary function testing has been long and evolving; now, ATS recommends this approach and a Boston hospital offers an implementation model. In July, ...

Shares of bioAffinity Technologies Inc. (NASDAQ:BIAF) climbed about 19% as investors reacted to developments surrounding the ...

NEW YORK (Reuters) - Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the pharmaceutical maker anticipates ...